According to filings with the U.S. Securities and Exchange Commission, Freespira is raising up to $22,578,792.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joseph Perekupka played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Freespira
Freespira is an FDA-cleared digital therapeutic proven to significantly reduce or eliminate Panic Disorder and PTSD symptoms by training users to normalize respiratory irregularities in just 28 days. Health plans, self-insured employers and the Veterans Administration use the companys drug-free solution to improve quality of life, reduce medical spending and support the appropriate use of valuable healthcare resources.

To learn more about Freespira, visit http://www.freespira.com/

Contact:
Joseph Perekupka, Chief Executive Officer
201-410-9629
https://www.linkedin.com/in/josephperekupka/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.